ATE437223T1 - Attenuiertes bovines respiratorisches syncytialvirus - Google Patents

Attenuiertes bovines respiratorisches syncytialvirus

Info

Publication number
ATE437223T1
ATE437223T1 AT01938170T AT01938170T ATE437223T1 AT E437223 T1 ATE437223 T1 AT E437223T1 AT 01938170 T AT01938170 T AT 01938170T AT 01938170 T AT01938170 T AT 01938170T AT E437223 T1 ATE437223 T1 AT E437223T1
Authority
AT
Austria
Prior art keywords
respiratory syncytial
bovine respiratory
attenuate
syncytial virus
viruses
Prior art date
Application number
AT01938170T
Other languages
English (en)
Inventor
Ulrike Schmidt
Ursula Buchholz
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Application granted granted Critical
Publication of ATE437223T1 publication Critical patent/ATE437223T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18561—Methods of inactivation or attenuation
AT01938170T 2000-06-23 2001-05-02 Attenuiertes bovines respiratorisches syncytialvirus ATE437223T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00202183 2000-06-23
PCT/EP2001/005085 WO2002002752A1 (en) 2000-06-23 2001-05-02 Attenuated bovine respiratory syncytial virus

Publications (1)

Publication Number Publication Date
ATE437223T1 true ATE437223T1 (de) 2009-08-15

Family

ID=8171676

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01938170T ATE437223T1 (de) 2000-06-23 2001-05-02 Attenuiertes bovines respiratorisches syncytialvirus

Country Status (9)

Country Link
US (2) US6921535B2 (de)
EP (1) EP1297110B1 (de)
AT (1) ATE437223T1 (de)
AU (1) AU2001263896A1 (de)
CA (1) CA2412075C (de)
DE (1) DE60139319D1 (de)
DK (1) DK1297110T3 (de)
ES (1) ES2330411T3 (de)
WO (1) WO2002002752A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60139319D1 (en) * 2000-06-23 2009-09-03 Intervet Int Bv Us
US7355716B2 (en) * 2002-01-24 2008-04-08 The General Hospital Corporation Apparatus and method for ranging and noise reduction of low coherence interferometry LCI and optical coherence tomography OCT signals by parallel detection of spectral bands
ES2670713T3 (es) 2003-12-24 2018-05-31 De Staat Der Nederlanden, Vert. Door De Minister Van Vws Virus sincitial respiratorio con una deficiencia genómica complementada en trans
ATE547511T1 (de) 2004-12-23 2012-03-15 Medimmune Llc Nichttumorbildende mdck-zellinie zur vermehrung von viren
EP2615167A1 (de) * 2006-09-15 2013-07-17 MedImmune, LLC Methode zur Beseitigung von DNA Rückständen in Virusaufreinigungen
CN102215865B (zh) 2008-09-24 2013-10-30 米迪缪尼有限公司 病毒纯化方法
RU2015103990A (ru) 2008-09-24 2015-10-27 Медиммун, Ллк Способы культивирования клеток, размножения и очистки вирусов
WO2010043039A1 (en) * 2008-10-16 2010-04-22 University Of Saskatchewan Combination adjuvant formulation
AR084358A1 (es) * 2010-12-27 2013-05-08 Lilly Co Eli Composiciones y metodos para identificar y diferenciar componentes virales de vacunas multivalentes de la “fiebre de embarque” (complejo de enfermedad respiratoria bovina (brdc))
CN105734007B (zh) * 2016-03-10 2019-06-07 金宇保灵生物药品有限公司 一种筛选对牛病毒性腹泻/黏膜病毒敏感的mdbk细胞系的方法
BR112021024409A2 (pt) * 2019-06-07 2022-01-18 Intervet Int Bv Célula mutante nocaute de mdbk irf3/irf7 e seu uso para produção de vacina

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2210273T5 (es) * 1994-07-18 2010-03-29 Conzelmann, Karl-Klaus, Prof. Dr. Virus con arn de cadena negativa no segmentado recombinante infeccioso.
BRPI9710363B8 (pt) 1996-07-15 2021-07-06 Us Gov Health & Human Serv partìcula de vìrus sincicial respirátorio recombinante (rsv) infeccioso atenuado, vacina para induzir proteção contra o vìrus sincicial respiratório recombinante (rsv), vetor de expressão, e, método de produção de um vìrus sincicial respiratório recombinante (rsv) infeccioso.
US6699476B1 (en) * 1996-07-15 2004-03-02 Peter L. Collins Production of recombinant respiratory syncytial viruses expressing immune modulatory molecules
EP0974660A1 (de) 1998-06-19 2000-01-26 Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) Newcastle-Krankheitsvirus Infektiöser Klone, Impfstoffe und Diagnosetest
DE60139319D1 (en) * 2000-06-23 2009-09-03 Intervet Int Bv Us

Also Published As

Publication number Publication date
EP1297110B1 (de) 2009-07-22
AU2001263896A1 (en) 2002-01-14
US20050186224A1 (en) 2005-08-25
WO2002002752A1 (en) 2002-01-10
EP1297110A1 (de) 2003-04-02
US7335366B2 (en) 2008-02-26
US6921535B2 (en) 2005-07-26
US20040037850A1 (en) 2004-02-26
ES2330411T3 (es) 2009-12-10
CA2412075C (en) 2011-09-20
CA2412075A1 (en) 2002-01-10
DK1297110T3 (da) 2009-11-16
DE60139319D1 (en) 2009-09-03

Similar Documents

Publication Publication Date Title
ATE437223T1 (de) Attenuiertes bovines respiratorisches syncytialvirus
EP1266025A4 (de) Proteingerüste für antikörper-mimetika und andere bindungsproteine
DE60328885D1 (de) Verfahren zur Beurteilung eines Krankheitzustandes mittels Nachweis von partikel- und nicht partikelgebundenen Nukleinsäuren in Blutplasma und -serum
WO2006110589A3 (en) Gammaretrovirus associated with cancer
ATE384785T1 (de) Herstellung von viren, virusisolaten, und impfstoffen
HUP0202532A2 (hu) Ko-stimulátor szignál-transzdukciós molekula (AILIM) elleni humán monoklonális antitest és gyógyászati alkalmazása
DE60236965D1 (de) Coronavirus-ähnliche partikel enthaltende funktionell deletierte genome
ATE439592T1 (de) Proteingerüste für antikörper-nachahmer und andere bindende proteine
DE602005013670D1 (de) Zusammensetzungen und verfahren zur quantifizierung von serumglykoproteinen
ATE492813T1 (de) Verfahren zur isolierung von analyten aus einer probe
DE69942708D1 (de) Virus enthaltende Zusammensetzungen und Methoden zur Konzentration von Viruspräparaten
EP2141243A3 (de) Proteingerüste für Antikörpermimetika und andere Bindungsproteine
HU230068B1 (hu) Nemhagyományos transzmisszibilis ágens biológiai mintabeli jelenlétének kimutatásán alapuló eljárás szubakut transzmisszibilis spongiform encephalopathia diagnózisára
DK0486515T3 (da) Fremgangsmåde til bestemmelse af den funktionelle aktivitet af frit protein S eller protein C i en plasmaprøve
ATE135371T1 (de) Mit akuter pankreatitis assoziiertes protein, mittel zur diagnose von akuter pankreatitis
CY1117746T1 (el) Αντιγονα αιμοφιλου της γριπης και αντιστοιχα θραυσματα dna
ATE363070T1 (de) Auswertung von biologischen mitteln in lebenden zielzellen
Barbeau et al. Identification and characterization of rift valley fever virus-specific T cells reveals a dependence on CD40/CD40L interactions for prevention of encephalitis
ATE309540T1 (de) Analytisches verfahren unter verwendung von multipelviren-markierung
DE602004030041D1 (de) Verfahren und zusammensetzungen zur identifikation von rna-bindenden proteinen
ATE311475T1 (de) Verfahren zur identifizierung von punkt mutationen in einem genom
ATE288589T1 (de) Verfahren zur analyse von proteinen
ATE267402T1 (de) Verfahren zur testung des hormonellen effekts von substanzen
ATE444354T1 (de) Attenuierter circovirus
Holmes et al. Coronavirus receptor specificity

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1297110

Country of ref document: EP

REN Ceased due to non-payment of the annual fee